Published in Clin Exp Gastroenterol on June 17, 2016
Gastrointestinal Disturbances Associated with the Consumption of Sugar Alcohols with Special Consideration of Xylitol: Scientific Review and Instructions for Dentists and Other Health-Care Professionals. Int J Dent (2016) 0.75
Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J (2017) 0.75
Integrative Medicine for Gastrointestinal Disease. Prim Care (2017) 0.75
The place of eluxadoline in the management of irritable bowel syndrome with diarrhea. Therap Adv Gastroenterol (2017) 0.75
New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench (2017) 0.75
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients (2017) 0.75
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study. Tech Coloproctol (2017) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol (2012) 4.78
No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology (2013) 4.52
Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology (1988) 4.06
Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther (2013) 3.89
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol (2008) 3.33
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut (2000) 3.26
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet (1982) 3.04
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.87
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology (2015) 2.85
Organic and functional disorders in 2000 gastroenterology outpatients. Lancet (1983) 2.78
Bran and irritable bowel syndrome: time for reappraisal. Lancet (1994) 2.68
Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA (2004) 2.67
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ (2009) 2.51
Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol (2012) 2.46
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology (1995) 2.29
The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil (2005) 2.11
Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion (2001) 2.05
Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther (2007) 2.04
Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.94
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 1.85
Management of the irritable bowel syndrome. Gastroenterology (2001) 1.83
Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol (2010) 1.79
Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc (2006) 1.77
Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol (2012) 1.72
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet (2011) 1.68
The brain-gut axis in abdominal pain syndromes. Annu Rev Med (2011) 1.68
Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther (2002) 1.67
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol (2009) 1.60
Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol (2003) 1.59
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med (2001) 1.59
Probiotics--compensation for lactase insufficiency. Am J Clin Nutr (2001) 1.57
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med (2001) 1.55
Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut (2014) 1.54
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion (1999) 1.44
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract (2013) 1.37
Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol (2013) 1.34
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther (2010) 1.24
Recurrent abdominal pain and lactose absorption in children. Pediatrics (1981) 1.19
Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes (2014) 1.19
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis (2008) 1.18
Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther (2005) 1.14
Visceral perception: inflammatory and non-inflammatory mediators. Gut (2002) 1.12
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07
Exclusion diets in irritable bowel syndrome: are they worthwhile? J Clin Gastroenterol (1987) 1.05
Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep (2012) 0.99
Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2014) 0.95
Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches. Altern Med Rev (2011) 0.95
Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep (2013) 0.94
New treatments for IBS. Nat Rev Gastroenterol Hepatol (2012) 0.94
Enteric and central contributions to intestinal dysmotility in irritable bowel syndrome. Dig Dis Sci (1992) 0.93
Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol (2014) 0.93
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease. Biomed J (2014) 0.91
The spectrum of irritable bowel syndrome: A clinical review. Clin Ther (2005) 0.91
The clinical relevance of lactose malabsorption in irritable bowel syndrome. Eur J Gastroenterol Hepatol (1996) 0.88
Irritable bowel syndrome: is the search for lactose intolerance justified? Eur J Gastroenterol Hepatol (2001) 0.88
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis (2007) 0.84
The autonomic nervous system in functional bowel disorders. Can J Gastroenterol (1999) 0.83
Dietary lactose and the child with abdominal pain. Br Med J (Clin Res Ed) (1983) 0.82
Abnormal accumulation of intestinal fluid following ingestion of an unabsorbable carbohydrate in patients with irritable bowel syndrome: an MRI study. Neurogastroenterol Motil (2014) 0.82
Randomized double blind placebo control studies, the "Gold Standard" in intervention based studies. Indian J Sex Transm Dis (2012) 0.78
Crohn's disease management after intestinal resection: a randomised trial. Lancet (2014) 5.83
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. Gastroenterology (2015) 1.97
Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus-Part 1). J Gastroenterol Hepatol (2016) 0.93
Asia-Pacific consensus statements on Crohn's disease. Part 2: Management. J Gastroenterol Hepatol (2016) 0.85
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nat Genet (2017) 0.83
Effect of intestinal resection on quality of life in Crohn's disease. J Crohns Colitis (2015) 0.77
Oxidation of calprotectin by hypochlorous acid prevents chelation of essential metal ions and allows bacterial growth: Relevance to infections in cystic fibrosis. Free Radic Biol Med (2015) 0.75
SEROLOGIC ANTIBODIES IN RELATION TO OUTCOME IN POST-OPERATIVE CROHN'S DISEASE. J Gastroenterol Hepatol (2016) 0.75